insights_auto
Why is PGEN down 2.58%?
Dive Deeperchevron_right
PGEN:NASDAQ
Precigen Inc
$4.54
arrow_downward
-2.58%(-0.12) 1D
$4.52
arrow_downward
-0.44% (-0.020)bedtimeAfter hours
Closed: Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PGEN...
Open
$4.66
High
$4.71
Low
$4.51
Mkt. cap
1.63B
Avg. vol.
6.85M
Volume
3.77M
P/E ratio
101.52
52-wk high
$8.98
52-wk low
$3.04
EPS
$0.04
Beta
1.01
Shares outstanding
358.55M
No. of employees
160
Open
$4.66
High
$4.71
Low
$4.51
Mkt. cap
1.63B
Avg. vol.
6.85M
Volume
3.77M
P/E ratio
101.52
52-wk high
$8.98
52-wk low
$3.04
EPS
$0.04
Beta
1.01
Shares outstanding
358.55M
No. of employees
160
News stories
From web sources and news partners
TradingView
·
2 hours ago
S&P 500 scores weekly advance despite Friday's tech-led decline
RealMoney Pro
·
34 minutes ago
Chips Slide Again, but the S&P 500 Still Ends the Week Up 2.5%
inkl
·
30 minutes ago
US Stock Market today: S&P 500, Nasdaq fall ahead of…
qz.com
·
1 hour ago
How much of the S&P 500 is Nvidia? Concentration explained
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc
CEOHelen Sabzevari
Employees160
FoundedMay 21, 1998
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteprecigen.com